Shen L, Kato K, Kim SB, Ajani JA, et al. Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study. J Clin Oncol 2022 Apr 20:JCO2101926. doi: 10.1200/JCO.21.01926.
PMID: 35442766